{"id":"W4391519272","doi":"10.1093/ecco-jcc/jjae013","title":"Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn’s Disease and 4 Years in Ulcerative Colitis","year":2024,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Janssen Research and Development; Allergan; Bausch Health; Celltrion; Boston Pharmaceuticals; BeiGene; Genentech; Janssen Scientific Affairs; Janssen Pharmaceuticals; Gilead Sciences; Mylan; Celgene; Biogen; GlaxoSmithKline; Tillotts Pharma; Seres Therapeutics; Amgen; Pfizer; Kiniksa Pharmaceuticals; Shire; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ustekinumab; Medicine; Internal medicine; Adverse effect; Inflammatory bowel disease; Placebo; Crohn's disease; Ulcerative colitis; Surgery; Infliximab; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03220881,0.001750872,0.005125715,0.00383736,0.0003354135,0.00180802,0.001018928,0.001795126,0.0016775],"category_scores_gemma":[0.02292444,0.0008648904,0.02477036,0.002490782,0.0005312691,0.001189621,0.001458312,0.00118474,0.0002177818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008847885,"about_ca_system_score_gemma":0.001121609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001401614,"about_ca_topic_score_gemma":0.001943926,"domain_scores_codex":[0.9827779,0.009263638,0.003033916,0.002099784,0.00233687,0.0004879139],"domain_scores_gemma":[0.9743872,0.009299777,0.01179179,0.001850216,0.002199766,0.000471205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1601056,0.0004851262,0.1537571,0.01570266,0.6004658,0.0002903872,0.0002549894,0.008488198,0.003125677,0.0002392433,0.00205016,0.05503504],"study_design_scores_gemma":[0.01895131,0.02639982,0.3767174,0.002100628,0.5607767,0.0006181354,0.0001689176,0.004581264,0.002771905,0.0008643238,0.005854039,0.0001955163],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6447044,0.3302462,0.01005102,0.0005600892,0.0004893427,0.001452907,0.009296092,0.0002430155,0.002957006],"genre_scores_gemma":[0.9740192,0.01742407,0.001917268,0.0003705908,0.0002861944,0.0006757049,0.004755277,0.00003039603,0.000521398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03220881,"threshold_uncertainty_score":0.1703385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005089426090467071,"score_gpt":0.243725997318994,"score_spread":0.2386365712285269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}